Tag: Hot flashes

According to the pharmaceutical information for Veozah (fezolinetant), consuming beverages containing caffeine is not recommended while taking this medication. This is because caffeine can significantly increase the levels of fezolinetant in the bloodstream, raising the risk of side effects. Patients should always consult their doctor or pharmacist regarding specific dietary recommendations when taking Veozah.

According to the FDA, in rare cases, the menopause drug Veozah (fezolinant) can cause serious liver injury and elevate liver blood test values. This critical safety information raises a serious concern for many users: **Does veozah raise liver enzymes?** The answer is yes, and understanding this risk is vital for anyone considering or currently taking the medication.

While a significant placebo effect exists for managing hot flashes, studies have shown that clonidine can reduce the frequency, severity, and duration of attacks more effectively than placebo. This medication, originally for blood pressure, is sometimes prescribed to determine whether **does clonidine help with flushing** for certain individuals, but its role has changed over time.

While excessive sweating, or hyperhidrosis, affects millions, a centrally acting alpha-adrenergic agonist called clonidine can be an effective treatment option for specific cases. Will clonidine help with sweating? For those exploring systemic medication options, understanding how this drug modulates the nervous system is key. This article details its mechanism, appropriate uses, potential drawbacks, and why it's typically not a first-line therapy.

Veozah (fezolinetant) is a non-hormonal treatment for moderate to severe vasomotor symptoms (VMS) due to menopause [1.5.4]. Combining it with your morning brew raises an important question: **Can you drink coffee while taking Veozah?** The answer involves understanding a key metabolic interaction.

Studies have shown that clonidine can moderately reduce the frequency and severity of hot flashes, particularly in postmenopausal women who cannot take hormonal replacement therapy. However, its effectiveness is often limited by side effects, and it is no longer considered a first-line treatment.

According to studies, gabapentin has demonstrated effectiveness in reducing the frequency and severity of hot flashes and night sweats in postmenopausal women. As an off-label use, it offers a non-hormonal option for managing vasomotor symptoms, but its suitability depends on individual health factors.

Up to 80% of women experience hot flashes and night sweats during the menopausal transition, prompting a search for effective, non-hormonal relief. In this context, the question of whether **can propranolol stop hot flashes** has been a subject of conflicting clinical studies and ongoing debate within the medical community.

In May 2023, the FDA approved Veozah (fezolinetant) as a non-hormonal treatment for hot flashes associated with menopause. However, in December 2024, the FDA added a Boxed Warning—its most prominent—after rare but serious liver injury cases were reported post-market. Knowing the answer to *Is Veozah safe to take?* involves a careful review of its risks, side effects, and necessary monitoring protocols.

As a once-daily medication, Veozah is effective for 24 hours in treating hot flashes and night sweats. The question of *is it better to take veozah at night or morning?* often depends on managing potential side effects like insomnia or addressing specific symptom timing.